These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33260174)
41. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
42. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells]. Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. RamÃrez-Moya J; Wert-Lamas L; Santisteban P Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884 [TBL] [Abstract][Full Text] [Related]
44. [Effect of miR-92b on migration, adhesion and invasion of human gastric cancer cell line SGC7901]. Wang W; Wang C; Jiang Y; Wu B Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1748-52. PubMed ID: 25537895 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
46. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines. Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway. Chai C; Song LJ; Han SY; Li XQ; Li M CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313 [TBL] [Abstract][Full Text] [Related]
48. [The role and mechanism of human trophoblastic cell surface antigen 2 in the invasion and metastasis of ovarian cancer]. Liu MB; Shi XF; Liu K; Song WY; Wang L; Wu HY; Wu GY Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):299-305. PubMed ID: 33752309 [No Abstract] [Full Text] [Related]
49. Transferred by exosomes-derived MiR-19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion. Zeng Q; Zhu Z; Song L; He Z Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146702 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
51. Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway. Liu X; Xu Y; Zhang L; Liu T; Zhang H Med Sci Monit; 2018 Jun; 24():4137-4145. PubMed ID: 29909423 [TBL] [Abstract][Full Text] [Related]
52. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance. Chen Y; Wang L; Zhou J J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer. Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811 [TBL] [Abstract][Full Text] [Related]
54. The effects of miR-140-5p on the biological characteristics of ovarian cancer cells through the Wnt signaling pathway. Wu Y; Li J; Chen S; Yu Z Adv Clin Exp Med; 2020 Jul; 29(7):777-784. PubMed ID: 32750755 [TBL] [Abstract][Full Text] [Related]
55. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN. Suo HB; Zhang KC; Zhao J Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595 [TBL] [Abstract][Full Text] [Related]
56. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition. Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
58. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T; Huang S; Han F Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [TBL] [Abstract][Full Text] [Related]
59. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
60. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway. Qin X; Sun L; Wang J Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]